Arrowhead Research reported $8.65M in Selling and Administration Expenses for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US $ 39.78M 4.94M
Alnylam Pharmaceuticals ALNY:US $ 166.29M 1.18M
Arena Pharmaceuticals ARNA:US $ 34.9M 15.9M
Arrowhead Research ARWR:US $ 8.65M 5.46M
Bluebird Bio BLUE:US $ 76.97M 8.93M
Cerulean Pharma CERU:US $ 1.38M 200.31K
Dicerna Pharmaceuticals DRNA:US $ 18.58M 1.62M
Heron Therapeutics HRTX:US $ 28.06M 6.06M
Intercept Pharmaceuticals ICPT:US $ 70.59M 1.44M
Ligand Pharmaceuticals LGND:US $ 30.08M 15.06M
Merk MRK:US $ 3.08B 640M
Mirati Therapeutics MRTX:US $ 25.34M 5.09M
Moderna Inc MRNA:US 78.99M 30.45M
Nektar Therapeutics NKTR:US $ 27.14M 154K
Novartis NOVN:VX 3.91B 496M
Opko Health OPK:US $ 101.82M 1.93M
Spectrum Pharmaceuticals SPPI:US $ 15.12M 372K
Ultragenyx Pharmaceutical RARE:US $ 51.04M 8.92M
Vertex Pharmaceuticals VRTX:US $ 211.84M 27.29M
Xencor XNCR:US $ 7.6M 33K
YTE INCY:US $ 166.99M 46.2M